1. At a Glance – The Great Indian Corn Story Gone… Slightly Sticky 🌽
Sanstar is that one company which took maize (yes, the same corn you eat at roadside bhutta stalls) and said: “Let’s turn this into a ₹1,445 crore valuation empire.” Sounds genius… until you realise they are selling glorified starch and glucose syrup — not iPhones.
On paper, it looks exciting: exports to 58 countries, big IPO, expansion from 1,100 TPD to 2,100 TPD, and dreams of becoming India’s #2 player. But then reality hits harder than a CA final exam result — margins are collapsing, profits are shrinking, and the stock is trading at a spicy 74x P/E. For a company whose core product is… starch.
Let that sink in.
Q3 FY26 numbers show a company trying to bounce back:
- Revenue: ₹2,018 million
- EBITDA: ₹179 million
- PAT: ₹137 million
But zoom out and you’ll see the real drama:
- 9M revenue down 22% YoY
- PAT down 63% YoY
So what’s going on? Is this a temporary hiccup because of expansion and China dumping starch globally? Or are we looking at a classic “IPO ke baad reality check”?
And most importantly — why is the market pricing this like a SaaS company when it literally crushes corn?
Let’s investigate this like a suspicious auditor who just smelled something funny in the balance sheet.
2. Introduction – IPO Dreams vs Ground Reality
Sanstar came to the market with a simple but powerful story:
👉 “India’s rising processed food demand + maize-based ingredients = multi-year growth story.”
And honestly, that narrative isn’t wrong.
India is consuming more:
- Packaged food
- Pharmaceuticals
- Animal nutrition products
All of these need starch derivatives. So the industry tailwind is very real.
But here’s where things get spicy.
Despite the growth story, Sanstar’s financials have started wobbling:
- FY24 revenue: ₹1,072 crore
- 9M FY25: ₹708 crore (down YoY)
Why?
👉 Maintenance shutdown
👉 Weak pricing
👉 Chinese dumping in export markets
👉 Commodity volatility
In short: this isn’t a high-margin tech business. It’s a commodity processing business wearing a growth-company costume.
And the market? It believed the costume.
Now ask yourself:
Are you investing in a “specialty chemical-style story”… or a “refined agriculture business”?
Because the valuation depends on that answer.
3. Business Model – WTF Do They Even Do?
Let’s simplify Sanstar’s business.
Step 1: Buy maize 🌽
Step 2: Crush it
Step 3: Extract:
- Starch
- Glucose
- Dextrose
- Animal feed
Step 4: Sell it to:
- Food companies
- Pharma companies
- Animal feed players
Basically:
👉 Corn → Chemical-ish products → Sold across industries
Revenue split:
- Food / Pharma: ~45%
- Animal nutrition: ~25%
- Industrial: ~30%
So yes, it’s diversified.
But here’s the catch:
👉 75–80% of cost = maize price
Meaning:
- If maize price rises → margins fall
- If maize price falls → margins improve
This is not a
